Microsemi Introduces MRI Industry's First Switching Dual Diodes Module


IRVINE, Calif., Oct. 25, 2005 (PRIMEZONE) -- Microsemi Corporation (Nasdaq:MSCC), a global manufacturer of high reliability semiconductors for the MRI clinical market, announced today that it has developed the industry's first MRI switching dual diodes module -- designed to optimize performance, eliminate polarity errors, and reduce system assembly labor and cost.



 -- Latest Microsemi breakthrough for MRI market
 -- Eliminates polarity mounting errors
 -- Reduces system assembly labor and cost
 -- RoHS Compliant

Designated the UMX9989AP(tm), Microsemi's new module is designed for two MRI system applications: providing MRI receiver protection from high RF energy fields, including long RF pulses and RF spike pulses; and passive switching of surface coil detuning and blocking circuits. It already has been recommended by a number of leading manufacturers of MRI high magnetic field systems having magnets of 1.5 Tesla strength or greater.

The new module's unique design provides two anti-parallel pairs of Microsemi UMX9989(tm) diodes, ensuring that the matched pair can be surface mounted into a coil assembly with correct polarities and with minimum parasitic inductance, minimum capacitance and minimum thermal impedance-all while reducing system assembly costs for the coil manufacturer.

According to a recent Frost & Sullivan survey of the MRI coils market, Very High Field coils that can employ Microsemi's new dual diode module, represent its fastest growing segment. It is expected to grow from 10.7% of the coils market in 2005 to 13.2% by 2009.

"This latest Microsemi breakthrough sets another standard for high performance MRI surface coil designs," said John Caruso, VP and General Manager of the company's Lowell, Massachusetts, operation. "It follows on the heels of our successful UMX5601(tm) diode, which also was a performance breakthrough and continues to be designed into many MRI systems," he added.

The UMX9989AP's superior performance results from a combination of innovative thermally matched packaging, low inductance Microsemi PIN diode silicon chips, and a proprietary construction process that uses full-faced metallurgical bonds to both surfaces of the chip. The device provides high power handling capability with a lower bias current requirement.

Noting that the MRI market Microsemi serves is expanding at greater than 18%, James J. Peterson, Microsemi President and CEO, said, "We intend to continue to apply our deep experience in high reliability semiconductor designs for the medical and aerospace markets to develop innovative products like this new ultra low magnetic module for MRI coil applications."

The UMX9989AP's proprietary dual surface mount module measures only .195" high x .175" wide x .090" deep and is RoHS compliant.

Complete technical information is available on the Microsemi web site, http://www.Microsemi.com. Samples can be requested through this site, from Microsemi sales representatives, or from Microsemi in Lowell at 978-442-5600.

About Microsemi Corporation

Microsemi Corporation, with corporate headquarters in Irvine, California, is a leading designer, manufacturer and marketer of high performance analog and mixed-signal integrated circuits and high reliability semiconductors. The company's semiconductors manage and control or regulate power, protect against transient voltage spikes and transmit, receive and amplify signals.

Microsemi's products include individual components as well as integrated circuit solutions that enhance customer designs by improving performance and reliability, battery optimization, reducing size or protecting circuits. The principal markets the company serves included implanted medical, defense/aerospace and satellite, notebook computers, monitors and LCD TVs, automotive and mobile connectivity applications. More information may be obtained by contacting the company directly or by visiting its web site at http://www.microsemi.com.

PLEASE READ THE FOLLOWING FACTORS THAT CAN MATERIALLY AFFECT MICROSEMI'S FUTURE RESULTS.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in the news release that are not entirely historical and factual in nature are forward-looking statements. For instance, all statements of belief and expectations are forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Potential risks and uncertainties include, but are not limited to, such factors as changes in generally accepted accounting principles, the difficulties regarding the making of estimates and projections, including difficulties with periodic fluctuation and possible changes of numerous factors, difficulties in the hiring and retention of qualified personnel in a competitive labor market, acquiring and integrating new operations or assets, closing or disposing of operations or assets, or difficulties in transferring work from one plant to another, rapidly changing technology and product obsolescence, difficulties predicting the timing and amount of plant closure costs, the potential inability to realize cost savings or productivity gains and to improve capacity utilization, potential cost increases, weakness or competitive pricing environment of the marketplace, uncertain demand for and acceptance of the company's products, results of in-process or planned development or marketing and promotional campaigns, changes in demand for products, difficulties foreseeing future demand, effects of limited visibility of future sales, potential non-realization of expected orders or non-realization of backlog, product returns, product liability, and other potential unexpected business and economic conditions or adverse changes in current or expected industry conditions, business disruptions, epidemics, disasters, wars or potential future effects of the tragic events of September 11, variations in customer order preferences, reductions or changes in defense spending, fluctuations in the costs of legal compliance, including compliance with the Sarbanes-Oxley Act of 2002, fluctuations in other costs of general and administrative kinds, fluctuations in market prices of the company's common stock and potential unavailability of additional capital on favorable terms, difficulties in implementing company strategies, dealing with environmental matters or litigation, difficulties in determining and maintaining adequate insurance coverage, difficulties protecting patents and other proprietary rights, inventory obsolescence and customer qualification of products, manufacturing facilities and processes. In addition to these factors and any other factors mentioned elsewhere in this news release, the reader should refer as well to the factors, uncertainties or risks identified in the company's most recent Form 10-K and subsequent Form 10-Q reports filed by Microsemi with the SEC. Additional risk factors shall be identified from time to time in Microsemi's future filings. Microsemi does not undertake to supplement or correct any information in this release that is or becomes incorrect.

Investor Inquiries: David R. Sonksen, Microsemi Corporation, Irvine, CA (949) 221-7101.

The Microsemi Corporation logo can be found at: http://www.primezone.com/newsroom/prs/?pkgid=1233



            

Contact Data